Date published: 2026-5-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Nrf2 Inhibitors

Nrf2 inhibitors belong to a specific class of chemical compounds that interact with the Nrf2 (Nuclear factor erythroid 2-related factor 2) signaling pathway within cells. The Nrf2 pathway is a crucial component of the body's cellular defense system, playing a key role in regulating the expression of genes involved in antioxidative stress responses and detoxification processes. Nrf2 is normally kept inactive by binding to a protein called Keap1 (Kelch-like ECH-associated protein 1) in the cytoplasm. However, when cells encounter oxidative stress or harmful stimuli, Nrf2 is released from Keap1 and translocates to the nucleus, where it triggers the expression of various protective genes. Nrf2 inhibitors work by disrupting this intricate regulatory mechanism. By interfering with the interaction between Nrf2 and Keap1, these inhibitors prevent the release and activation of Nrf2. As a result, the transcription of genes involved in antioxidant defense and detoxification processes is downregulated, hindering the cell's ability to combat oxidative stress and harmful substances. The modulation of the Nrf2 pathway through inhibitors has drawn significant attention in the scientific community due to its potential implications in various biological processes. Researchers are actively studying these compounds to better understand their mechanisms of action and how they could be utilized to investigate the complex regulatory networks within cells. Furthermore, exploring the effects of Nrf2 inhibitors on cellular responses can provide valuable insights into the intricate interplay between oxidative stress, cell signaling, and gene expression, which could have broader implications for understanding cellular health and disease mechanisms. Overall, Nrf2 inhibitors represent a fascinating class of chemicals with significant potential for research and exploration in various scientific disciplines.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CDDO Methyl Ester

218600-53-4sc-504720
10 mg
$220.00
(0)

CDDO Methyl Ester is an investigational drug that activates NFE2L2 and has been studied for its potential therapeutic effects in various diseases.

Betulin

473-98-3sc-234016
1 g
$102.00
5
(1)

Betulin has been shown to activate NFE2L2 and induce antioxidant response.

Sodium (meta)arsenite

7784-46-5sc-250986
sc-250986A
100 g
1 kg
$108.00
$780.00
3
(2)

Sodium arsenite has been reported to activate NFE2L2 and promote the expression of antioxidant genes.